MB-CART2019.1 in Refractory Multiple Sclerosis

Clinical trial NCT07178431 · RECRUITING

Trial details

NCT number: NCT07178431
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis CAR T Cell Therapy

Start date: 2026-04-01
Primary completion: 2030-08-16
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.